An ENU-induced mutation in the lymphotoxin α gene impairs organogenesis of lymphoid tissues in C57BL/6 mice

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 461-467

  Wang, Hongsheng ^a   Feng, Jianxun ^a   Qi, Chenfeng ^a   Morse III, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

B1b; Bone marrow; ENU; Leukocytosis; Lymph node; Lymph organogenesis; Marginal zone; Spleen; Thymus

Indexed keywords

ETHYLNITROSOUREA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BASE PAIRING; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE; GENE FUNCTION; GENE MUTATION; GENETIC CODE; GERMINAL CENTER; HISTOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; LTA GENE; LYMPH NODE; LYMPHOID TISSUE; MICROSCOPY; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGANOGENESIS; PERITONEUM CELL; PEYER PATCH; POINT MUTATION; PRIORITY JOURNAL; STOP CODON; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CHROMOSOME MAPPING; DENDRITIC CELLS; ETHYLNITROSOUREA; GRANULOCYTES; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C57BL; ORGANOGENESIS; PERITONEUM; PEYER'S PATCHES; POINT MUTATION; T-LYMPHOCYTES;

MUS;

EID: 43049120926     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.118     Document Type: Article

References (27)

1. Tumanov A.V., Kuprash D.V., and Nedospasov S.A. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev. 14 (2003) 275-288
2. Pasparakis M., Alexopoulou L., Grell M., Pfizenmaier K., Bluethmann H., and Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 6319-6323
3. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., and Old L.J. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 8093-8098
4. Kuprash D.V., Tumanov A.V., Liepinsh D.J., Koroleva E.P., Drutskaya M.S., Kruglov A.A., Shakhov A.N., Southon E., Murphy W.J., Tessarollo L., Grivennikov S.I., and Nedospasov S.A. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur. J. Immunol. 35 (2005) 1592-1600
5. Koni P.A., and Flavell R.A. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta. J. Exp. Med. 187 (1998) 1977-1983
6. Qi C.F., Xiang S., Shin M.S., Hao X., Lee C.H., Zhou J.X., Torrey T.A., Hartley J.W., Fredrickson T.N., and Morse III H.C. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. Leuk. Res. 30 (2006) 153-163
7. Wang H., Ye J., Arnold L.W., McCray S.K., and Clarke S.H. A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J. Immunol. 167 (2001) 1254-1262
8. Justice M.J., Noveroske J.K., Weber J.S., Zheng B., and Bradley A. Mouse ENU mutagenesis. Hum. Mol. Genet. 8 (1999) 1955-1963
9. Harbach P.R., Mattano S.S., Zimmer D.M., Filipunas A.L., Wang Y., and Aaron C.S. DNA sequence analysis of hprt mutants persisting in peripheral blood of cynomolgus monkeys more than two years after ENU treatment. Environ. Mol. Mutagen. 33 (1999) 42-48
10. Quwailid M.M., Hugill A., Dear N., Vizor L., Wells S., Horner E., Fuller S., Weedon J., McMath H., Woodman P., Edwards D., Campbell D., Rodger S., Carey J., Roberts A., Glenister P., Lalanne Z., Parkinson N., Coghill E.L., McKeone R., Cox S., Willan J., Greenfield A., Keays D., Brady S., Spurr N., Gray I., Hunter J., Brown S.D., and Cox R.D. A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome 15 (2004) 585-591
11. Keays D.A., Clark T.G., Campbell T.G., Broxholme J., and Valdar W. Estimating the number of coding mutations in genotypic and phenotypic driven N-ethyl-N-nitrosourea (ENU) screens: revisited. Mamm. Genome 18 (2007) 123-124
12. Browning J.L., Sizing I.D., Lawton P., Bourdon P.R., Rennert P.D., Majeau G.R., Ambrose C.M., Hession C., Miatkowski K., Griffiths D.A., Ngam-ek A., Meier W., Benjamin C.D., and Hochman P.S. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 159 (1997) 3288-3298
13. Alexopoulou L., Pasparakis M., and Kollias G. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function. J. Exp. Med. 188 (1998) 745-754
14. Bopst M., Garcia I., Guler R., Olleros M.L., Rulicke T., Muller M., Wyss S., Frei K., Le Hir M., and Eugster H.P. Differential effects of TNF and LTalpha in the host defense against M. bovis BCG. Eur. J. Immunol. 31 (2001) 1935-1943
15. Liepinsh D.J., Grivennikov S.I., Klarmann K.D., Lagarkova M.A., Drutskaya M.S., Lockett S.J., Tessarollo L., McAuliffe M., Keller J.R., Kuprash D.V., and Nedospasov S.A. Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol. Cell. Biol. 26 (2006) 4214-4225
16. Fu Y.X., Huang G., Matsumoto M., Molina H., and Chaplin D.D. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl. Acad. Sci. USA 94 (1997) 5739-5743
17. Banks T.A., Rouse B.T., Kerley M.K., Blair P.J., Godfrey V.L., Kuklin N.A., Bouley D.M., Thomas J., Kanangat S., and Mucenski M.L. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155 (1995) 1685-1693
18. Sean Riminton D., Korner H., Strickland D.H., Lemckert F.A., Pollard J.D., and Sedgwick J.D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187 (1998) 1517-1528
19. Korner H., Winkler T.H., Sedgwick J.D., Rollinghoff M., Basten A., and Cook M.C. Recirculating and marginal zone B cell populations can be established and maintained independently of primary and secondary follicles. Immunol. Cell Biol. 79 (2001) 54-61
20. Pokholok D.K., Maroulakou I.G., Kuprash D.V., Alimzhanov M.B., Kozlov S.V., Novobrantseva T.I., Turetskaya R.L., Green J.E., and Nedospasov S.A. Cloning and expression analysis of the murine lymphotoxin beta gene. Proc. Natl. Acad. Sci. USA 92 (1995) 674-678
21. Muller U., Jongeneel C.V., Nedospasov S.A., Lindahl K.F., and Steinmetz M. Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature 325 (1987) 265-267
22. Lawton P., Nelson J., Tizard R., and Browning J.L. Characterization of the mouse lymphotoxin-beta gene. J. Immunol. 154 (1995) 239-246
23. Seidl K.J., Manis J.P., Bottaro A., Zhang J., Davidson L., Kisselgof A., Oettgen H., and Alt F.W. Position-dependent inhibition of class-switch recombination by PGK-neor cassettes inserted into the immunoglobulin heavy chain constant region locus. Proc. Natl. Acad. Sci. USA 96 (1999) 3000-3005
24. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., Smith S.C., Carlson R., Shornick L.P., Strauss-Schoenberger J., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264 (1994) 703-707
25. Ito D., Back T.C., Shakhov A.N., Wiltrout R.H., and Nedospasov S.A. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment. J. Immunol. 163 (1999) 2809-2815
26. Smyth M.J., Johnstone R.W., Cretney E., Haynes N.M., Sedgwick J.D., Korner H., Poulton L.D., and Baxter A.G. Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice. J. Immunol. 163 (1999) 1350-1353
27. Grech A.P., Riminton D.S., Gabor M.J., Hardy C.L., Sedgwick J.D., and Godfrey D.I. Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted mice. Dev. Immunol. 8 (2000) 61-74